PET Scientist

At Clario, a part of Thermo Fisher Scientific, we develop regulated technology that helps unlock better evidence and improve patient outcomes worldwide. Our scientific, imaging, and technology teams support global clinical trials in highly regulated environments, delivering high‑quality imaging endpoints that advance neuroscience research. In this role, you will collaborate with multidisciplinary teams to support molecular imaging studies in neuroscience clinical trials. You will play a key role in PET and SPECT imaging deployment, image acquisition quality, data analysis, and innovation, working closely with radiologists, physicists, scientists, engineers, and operational teams. What We Offer Competitive compensation Comprehensive health, dental, and vision coverage Retirement savings plan with company contribution Paid time off and company holidays What You'll Be Doing Collaborate with neuroradiologists, physicists, scientists, software engineers, and operational specialists on study documentation, scan acquisition, quality control, and image analysis Evaluate, train, and support PET and SPECT imaging facilities participating in neuroscience clinical trials Lead deployment of advanced molecular imaging (PET and SPECT) acquisition across heterogeneous imaging sites worldwide Assist with scripting, execution, and validation of large‑scale image processing and analysis workflows Support publication of imaging analysis results and scientific outputs Contribute to innovation initiatives and business development efforts Read, understand, and adhere to organizational Standard Operating Procedures (SOPs) Assist in establishing, maintaining, and enforcing departmental standards Collaborate with internal teams to resolve study‑related or technical issues Identify opportunities to enhance processes, workflows, and scientific value Support abstract and manuscript preparation for scientific dissemination Participate in company‑sponsored training and professional development activities Perform other duties as assigned What We Look For PhD in biomedical engineering, physics, neuroscience, or a related field 5+ years of hands‑on experience in molecular imaging, including PET, SPECT, and novel tracers Strong working knowledge of molecular imaging and nuclear medicine physics and terminology across imaging vendors Proven ability to manipulate, process, and analyze medical imaging data Demonstrated problem‑solving skills in complex scientific or technical environments Programming experience (e.g., MATLAB, Python) preferred Excellent written and verbal communication skills Strong attention to detail and commitment to high‑quality scientific work Ability to work independently and collaboratively in a global, cross‑functional environment Strong documentation, organizational, and time‑management skills Professional, positive, and adaptable mindset At Clario, a part of Thermo Fisher Scientific, our purpose is to transform lives by unlocking better evidence. It's a cause that unites and inspires us. It's why we come to work—and how we empower our people to make a positive impact every day. Whether you're advancing clinical science, supporting innovative technology, or collaborating with global teams, your work helps bring life‑changing therapies to patients faster. Clario is an equal opportunity employer. Clario evaluates qualified applicants without regard to race, color, religion, gender, national origin, age, sexual orientation, gender identity or expression, protected veteran status, disability/handicap status, or any other legally protected characteristic. Clario Privacy Policy Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for life sciences companies. We offer comprehensive evidence generation solutions that combine medical imaging, eCOA, precision motion, cardiac solutions and respiratory endpoints. For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported over 30,000 clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 70% of all FDA drug approvals since 2015.